<DOC>
	<DOCNO>NCT01793272</DOCNO>
	<brief_summary>To evaluate effect pentoxifylline use preparation semen sample use ICSI infertile men complain mild moderate asthenozoospermia ( i.e . case need motility enhancement prior ICSI ) comparison semen sample without pentoxifylline preparation outcome ICSI .</brief_summary>
	<brief_title>Beneficial Effect Adding Pentoxifylline Processed Semen Samples ICSI Outcome Infertile Males</brief_title>
	<detailed_description>The primary outcome measure number oocytes retrieve , number oocyte inject , number oocyte fertilize , fertilization rate , number embryos quality ( G1 : good embryo , G2 : fair embryos G3 : bad embryo ) , number embryo transfer ( ET ) , number embryo sac , embryo implantation rate , pregnancy rate abortion rate 3 group pregnancy rate abortion rate group ( I ) group ( II ) .</detailed_description>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>seek ICSI infertility Pyospermia , presence antisperm antibody . Azoospermia , severe male factor , severe asthenozoospermia . Past history orchitis . Patients receive empirical treatment asthenozoospermia e.g . oral Pentoxifylline , lcarnitine antioxidant past 3 6 month . Diabetics , hypertensives patient chronic systemic illness . Wife 's age 35 year . Low antral count . Presence ovarian factor contribute infertility e.g . polycystic ovary .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>